These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 8672093)

  • 1. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages.
    Rastogi N; Labrousse V; Goh KS
    Curr Microbiol; 1996 Sep; 33(3):167-75. PubMed ID: 8672093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis.
    Fattorini L; Iona E; Ricci ML; Thoresen OF; Orrù G; Oggioni MR; Tortoli E; Piersimoni C; Chiaradonna P; Tronci M; Pozzi G; Orefici G
    Microb Drug Resist; 1999; 5(4):265-70. PubMed ID: 10647084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis.
    Rastogi N; Goh KS; Bryskier A; Devallois A
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1610-6. PubMed ID: 8807049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Using of the Sensititre MycoTB Plate Method for the Detection of Anti-tuberculous Drug Susceptibility of Rifampin Resistant Mycobacterium tuberculosis Complex Isolates].
    Ceyhan İ; Vezir S
    Mikrobiyol Bul; 2020 Apr; 54(2):211-222. PubMed ID: 32723277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
    Bhusal Y; Shiohira CM; Yamane N
    Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of twelve second-line antimicrobial agents against Mycobacterium tuberculosis in Taiwan.
    Lu PL; Peng CF; Hwang JJ; Chen YH
    J Chemother; 2008 Apr; 20(2):202-7. PubMed ID: 18467246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosis.
    Rastogi N; Ross BC; Dwyer B; Goh KS; Clavel-Sérès S; Jeantils V; Cruaud P
    Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):901-7. PubMed ID: 1362540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antituberculosis activity of clarithromycin.
    Luna-Herrera J; Reddy VM; Daneluzzi D; Gangadharam PR
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2692-5. PubMed ID: 8593004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
    De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
    J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of extensive drug resistance in multidrug resistance tuberculosis isolates].
    Bektöre B; Haznedaroğlu T; Baylan O; Ozyurt M; Ozkütük N; Satana D; Cavuşoğlu C; Seber E
    Mikrobiyol Bul; 2013 Jan; 47(1):59-70. PubMed ID: 23390903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 24-well plate assay for simultaneous testing of first and second line drugs against Mycobacterium tuberculosis in a high endemic setting.
    Wedajo W; Schön T; Bedru A; Kiros T; Hailu E; Mebrahtu T; Yamuah L; Ängeby K; Werngren J; Onyebujoh P; Dagne K; Aseffa A
    BMC Res Notes; 2014 Aug; 7():512. PubMed ID: 25108648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of two methods for the detection of antituberculous drug susceptibility in Mycobacterium tuberculosis complex isolates: sensititre MycoTB MIC plate and the indirect agar proportion methods].
    Varıcı Balcı FK; Çavuşoğlu C
    Mikrobiyol Bul; 2018 Apr; 52(2):123-134. PubMed ID: 29933730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophages.
    Mor N; Esfandiari A
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2035-6. PubMed ID: 9303411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine.
    Rastogi N; Goh KS; Bryskier A; Devallois A
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2483-7. PubMed ID: 8913450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Mycobacterium tuberculosis activities of new fluoroquinolones in combination with other antituberculous drugs.
    Tomioka H; Sato K; Shimizu T; Sano C
    J Infect; 2002 Apr; 44(3):160-5. PubMed ID: 12099742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
    Huang CC; Wu MF; Chen HC; Huang WC
    J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis.
    Cavalieri SJ; Biehle JR; Sanders WE
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1542-5. PubMed ID: 7492101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
    Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
    J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Whole-Genome Sequencing to Predict
    Wu X; Tan G; Sha W; Liu H; Yang J; Guo Y; Shen X; Wu Z; Shen H; Yu F
    Microbiol Spectr; 2022 Apr; 10(2):e0251621. PubMed ID: 35311541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.